CD8A and neoplasm: Furthermore, Cu2-xSe has the ability to modulate the phenotypic polarization of TAMs, increase IFN-γ production by CD8+T cells, and develop a combined therapeutic protocol that simultaneously activates ferroptosis, copper-dependent cell death, and anti-tumor immune responses (Li K. et al., 2023).